Flow Medical
Chicago, US · 2 known investors
Flow Medical develops technology for catheter-directed thrombolysis treatment of pulmonary embolism, aiming to improve precision in lytic medication dosing to reduce readmission rates. The company targets interventional cardiologists and radiologists managing acute PE cases.
